Publication: 3473

Publication: 3473

Everolimus With or Without Bevacizumab in Advanced pNET: CALGB 80701 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Endocr Relat Cancer vol 29 (6) 335-344

Year:: 2022
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pmc-release

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:: 11

Parents:: 2290 2384
Children:: None

Program:: OGC
Primary Committee:: GI
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882, UG1CA233180, UG1CA233290, UG1CA233337, U10CA180863 (CCTG), U10CA180888 (SWOG)

Corr. Author:
Authors:: Matthew H. Kulke Fang-Shu Ou Donna Niedzwiecki Lucas Huebner Pamela Kunz Hagen F. Kennecke Edward M. Wolin Jennifer A Chan Eileen M. O'Reilly Jeffrey A. Meyerhardt Alan Venook

Networks:: CA824, LAPS-CT018, LAPS-MA036, LAPS-MN026, LAPS-NY016, NY021, OR013

Study: CALGB-80701
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords:: Pancreatic neuroendocrine tumor, everolimus, bevacizumab, clinical trial